A novel preclinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity. [electronic resource]
Producer: 20120207Description: 1401-9 p. digitalISSN:- 1524-4571
- Animals
- Animals, Genetically Modified
- Apoptosis -- drug effects
- Benzenesulfonates -- pharmacology
- Cardiotoxins -- pharmacology
- Cell Survival -- drug effects
- Cells, Cultured
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- Female
- Gefitinib
- Indoles -- pharmacology
- Male
- Models, Animal
- Myocytes, Cardiac -- cytology
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Proto-Oncogene Proteins c-raf -- antagonists & inhibitors
- Pyridines -- pharmacology
- Pyrroles -- pharmacology
- Quinazolines -- pharmacology
- Rats
- Rats, Sprague-Dawley
- Signal Transduction -- drug effects
- Sorafenib
- Sunitinib
- Zebrafish
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.